docetaxel anhydrous has been researched along with Chondrosarcoma, Mesenchymal in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agur, Z; Gorelik, B; Hankins, WD; Shohat, R; Sidransky, D; Wick, M; Ziv, I | 1 |
1 other study(ies) available for docetaxel anhydrous and Chondrosarcoma, Mesenchymal
| Article | Year |
|---|---|
Efficacy of weekly docetaxel and bevacizumab in mesenchymal chondrosarcoma: a new theranostic method combining xenografted biopsies with a mathematical model.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biopsy; Bone Neoplasms; Chondrosarcoma, Mesenchymal; Docetaxel; Drug Administration Schedule; Humans; Male; Mice; Middle Aged; Models, Theoretical; Taxoids; Transplantation, Heterologous | 2008 |